IDEXX Laboratories Inc. (IDXX) News
Filter IDXX News Items
IDXX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IDXX News Highlights
- IDXX's 30 day story count now stands at 20.
- Over the past 24 days, the trend for IDXX's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about IDXX are PET, SNAP and ALC.
Latest IDXX News From Around the Web
Below are the latest news stories about IDEXX LABORATORIES INC that investors may wish to consider to help them evaluate IDXX as an investment opportunity.
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) received a lot of attention from a substantial price increase on the NASDAQGS... |
ALC or IDXX: Which Is the Better Value Stock Right Now?ALC vs. IDXX: Which Stock Is the Better Value Option? |
IDEXX Laboratories (IDXX) Declined on Weak Clinical Visits Across the IndustryConestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite declined 8.01% net of fees in the third quarter, trailing the Russell Midcap Growth Index’s -5.22% return. A combination of negative stock selection and sector allocation effects resulted […] |
IDEXX's (IDXX) Upcoming Launch to Detect Canine LeishmaniosisIDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis. |
IDEXX Laboratories (IDXX) Fell on Investors’ ConcernsBaron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter. Against this backdrop, the Baron Asset Fund declined 4.42% (Institutional Shares) in the […] |
Investors in IDEXX Laboratories (NASDAQ:IDXX) have seen solid returns of 113% over the past five yearsWhile IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) shareholders are probably generally happy, the stock hasn't had... |
Here's Why You Should Invest in IDEXX (IDXX) Stock Right NowInvestors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business and momentum in ProCyte One expansion. |
IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne DiseasesIDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the upcoming launch of the SNAP® Leish 4Dx® Test, a comprehensive screening test for vector-borne diseases, including canine leishmaniosis. The SNAP Leish 4Dx Test uses the trusted SNAP 4Dx Plus testing platform, which detects Lyme disease, heartworm disease, ehrlichiosis, and anaplasmosis. By replacing Lyme disease detection with detection of leishmaniosis, a more prevalent endemic disease in certai |
IDEXX Laboratories Insiders Sold US$4.5m Of Shares Suggesting HesitancyOver the past year, many IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) insiders sold a significant stake in the company... |
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?With its stock down 17% over the past three months, it is easy to disregard IDEXX Laboratories (NASDAQ:IDXX). However... |